Why Pfizer's Future Looks Better in 2021
Despite the success of its COVID-19 vaccine program, Pfizer (NYSE: PFE) didn't impress investors with its stock performance last year. That could change going forward, though. In this Motley Fool Live video recorded on Jan. 13, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com writer Keith Speights discuss why Pfizer's future looks better in 2021.
Source Fool.com
